 Karnofsky performance status of 50 Concurrent or previous second primary cancer excluding non-melanoma skin cancer Gross residual disease following surgery Distant metastasis before or at the time of adjuvant treatment Serum creatinine 1.4 mgdl, WBC 3500mm3, platelet 100,000mm3 